Digital Health are software tools used to prevent or treat a variety of disorders, either on their own or alongside traditional medicines. There is a lot of excitement around this space due to their ability to provide help in areas that have been previously underserved, such as diabetes, mental health, hypertension and pain management. As employees are becoming increasingly health conscious and digitally skilled, they are taking an active role in managing their health and seeking out innovative products and services. Our unique seminar gives you an opportunity to learn how to integrate Digital Health Solutions to achieve a happier, healthier and more productive workforce.
Last week we attended DTx Europe, a forum for the emerging Digital Therapeutics industry. After two days of insightful presentations, panel discussions and many caffeine-infused chats with startups, pharma companies and investors, our heads might still be spinning, but a few things have crystallised in our minds:
Today we look at the global diet analysis published by Lancet on April 3, and focus on a few opportunities that it opens up for the cereal industry.
The key conclusion of the 27 year global study (195 countries) is that poor diet accounts for more deaths than other risk factors such as smoking.
Another critical finding is that in most cases the more important factor is not what we eat too much of, but rather what we don’t eat enough of. Apart from salt - we consume far too much of it. More than half of all global diet-related deaths in 2017 within this global study were due to just three risk factors: too much salt, and not enough whole grains and fruit.
It’s common knowledge that health systems around the world are under incredible cost pressure, and everyone would love to find sustainable solutions to this problem. Is digital therapeutics the magic pill everyone has been looking for?
Our research shows that there is potentially massive value in digital therapeutics, and to some extent, this has already been proven. In this paper, we look at where the value sits, and how incumbents, upstarts and venture and private equity investors could unlock it.